| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.38 | 0.0007 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0008 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.003 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.28 | 0.006 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |